AMERISAFE, Inc. filings document formal disclosures for a Nasdaq-listed specialty workers’ compensation insurer focused on high-hazard industries. Form 8-K reports cover financial results, dividend announcements, the reauthorization of a common stock repurchase program and executive officer changes, including related employment-agreement disclosures.
The company’s proxy materials cover annual meeting matters, director elections, board governance, executive compensation and shareholder voting items. Cover-page disclosures identify AMERISAFE common stock, par value $0.01 per share, traded under AMSF on the Nasdaq Stock Market.
TRAYNOR SEAN reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC director Sean Traynor received a stock award of 2,340 shares of common stock. The shares were granted at no cash cost as a compensation-related award and are subject to restrictions that will lapse at the time of the company’s 2027 annual meeting of shareholders.
Following this grant, Traynor directly holds a total of 18,326 AMERISAFE common shares, reflecting a routine increase in his equity stake tied to board service.
Roach Randy reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC director Randy Roach received a stock grant of 2,340 shares of common stock on June 10, 2026, at no cash cost per share. These shares are subject to restrictions that lapse at the company’s 2027 annual meeting of shareholders. After the grant, Roach directly holds 18,862 shares.
BROWN MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC director Michael J. Brown received a grant of 2,340 shares of common stock on June 10, 2026. The shares were awarded at no cash cost to him as equity compensation.
The award is subject to restrictions that will lapse at the issuer's 2027 annual meeting of shareholders. Following this grant, Brown directly holds 15,761 shares of AMERISAFE common stock.
AMERISAFE, Inc. director Teri G. Fontenot reported an equity award of common stock. She acquired 2,340 shares of common stock at a stated price of $0.00 per share as a grant, not an open-market purchase.
The award is subject to restrictions that will lapse at the time of AMERISAFE's 2027 annual meeting of shareholders. After this grant, Fontenot directly holds 14,008 shares of AMERISAFE common stock.
AMERISAFE, Inc. reported results of its 2026 annual shareholder meeting held on June 10, 2026 at its DeRidder, Louisiana headquarters. Shareholder turnout was high, with 17,128,230 shares represented out of 18,703,771 common shares outstanding as of the April 16, 2026 record date.
Shareholders approved technical amendments to the company’s Certificate of Formation and the company filed an Amended and Restated Certificate of Formation with the Texas Secretary of State that implements these clarifying changes. However, shareholders did not approve a separate amendment that would have provided for officer exculpation, so that change was not included.
All three director nominees — Michael J. Brown, G. Janelle Frost and Sean M. Traynor — were elected, each receiving over 15.1 million votes in favor, with relatively low votes withheld and substantial broker non-votes reported.
AMERISAFE Inc. executive Guillermo A. Ramos, EVP and Chief Financial Officer, received a new equity award in the form of restricted stock units. On this grant, he acquired 2,970 restricted stock units, each representing a contingent right to receive one share of AMERISAFE common stock.
The restricted stock units fully vest on March 1, 2029, meaning he will receive the underlying shares only if the vesting conditions are satisfied through that date. Following this award, his directly held restricted stock units increased to 35,973, aligning his compensation further with long-term shareholder value.
Ramos Guillermo A reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC executive Guillermo A. Ramos, EVP and Chief Financial Officer, received a grant of 33,003 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of AMERISAFE common stock. Following this grant, he holds 33,003 restricted stock units directly.
The award vests over four years in annual installments of 15%, 20%, 30% and 35%, beginning on May 7, 2027, the first anniversary of the grant date. This structure links a significant portion of the executive’s compensation to the company’s long-term share performance and continued service.
AMERISAFE INC executive Guillermo A. Ramos, the company’s EVP and Chief Financial Officer, filed a Form 3 as an initial statement of beneficial ownership. The filing does not list any transactions or holdings, serving primarily to register his status as a reporting officer under SEC rules.
AMERISAFE Inc reports that Vanguard Capital Management beneficially owns 994,816 shares of Common Stock, representing 5.29% of the class. The filing shows sole voting power for 145,788 shares and sole dispositive power for 994,816 shares as reported.
Lestage Henry O IV reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC granted executive compensation in stock-based form. EVP and Chief Claims Officer Henry O. Lestage IV received 1,991 restricted stock units, each representing a contingent right to one share of common stock. These restricted stock units fully vest on March 1, 2029, if vesting conditions are met.
Following this grant, Lestage directly holds 24,112 shares or share-equivalents in total, indicating this is a routine, compensation-related equity award rather than a market purchase or sale.